The Journal of Clinical Investigation family of journals To view or add a comment, sign in Retatrutide (LY-3437943) is a next-generation triple incretin receptor agonist that simultaneously activates the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R)
Biomarker assessment helps stratify risk and inform dosing decisions
Monitoring Paragraph IV dockets through litigation tracking services and tools like DrugPatentWatch surfaces these settlement events early enough to adjust sourcing plans before budget cycles lock in brand drug spending assumptions
Dehydration often accompanies tirzepatide use because nausea and reduced appetite may lead to lower fluid intake
The study, which involved participants with type-2 diabetes, showed that a pre-meal drink containing 10 grams of Nestles whey protein microgels lowered glucose response and increased the release of GLP-1, the gut hormone that helps to regulate blood sugar levels, slow digestion and increase satiety